Burcon to Host Virtual Investor Presentation on February 18, 2025

Rhea-AI Summary

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a leader in plant-based protein technology, has announced a virtual Investor Presentation scheduled for February 18, 2025, at 5:00 p.m. Eastern time. The presentation will be led by CEO Kip Underwood to discuss recent company milestones.

The event will cover key topics including: the company's route to market through facility acquisition by alliance partner Re ProMan , plans to bring their entire protein portfolio to market with full operational control, details about their Rights Offering, and future plans. A live Q&A session will follow the presentation.

Investors can participate through a webcast available on Burcon's website under 'Presentations' or join via phone using toll-free number 1-800-717-1738 (North America) or 1-646-307-1865 (International) with Conference ID: 37581. Questions can be submitted in advance to plam@burcon.ca.

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold a virtual Investor Presentation on Tuesday, February 18, 2025 at 5:00 p.m. Eastern time to review the Company's recent milestones.

"Our recent accomplishments establish the foundation for Burcon's future success," said Kip Underwood, Burcon's chief executive officer. "With a clear path to market for all our protein technologies, we are eager to begin production and drive revenue growth."

This virtual event will feature a presentation from Burcon management and a moderated Q&A session. The topics covered will include:

• Route to market with facility acquisition by Re ProMan LLC ("ProMan"), Burcon's alliance partner
• Plan to bring entire protein portfolio to market with full operational control
• Rights Offering
• Future Plans

A live Q&A session will follow the formal presentation. Attendees wishing to have a question addressed at the event can submit them in advance to plam@burcon.ca.

Event Details

A link to the webcast of the conference call is available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future playback.

Investors interested in participating in the live call can dial in using the details below:

Date: Tuesday February 18, 2025

Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)

Toll-free dial-in (North America): 1-800-717-1738

Dial-in (toll/international): 1-646-307-1865

Conference ID: 37581

About Burcon NutraScience Corporation

Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.

Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240366

FAQ

When is Burcon NutraScience's (BRCNF) virtual investor presentation in 2025?

Burcon's virtual investor presentation is scheduled for Tuesday, February 18, 2025, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time).

What topics will be covered in Burcon's (BRCNF) February 2025 investor presentation?

The presentation will cover the route to market with ProMan facility acquisition, plans to bring their protein portfolio to market, Rights Offering details, and future plans.

How can investors participate in Burcon's (BRCNF) February 2025 virtual presentation?

Investors can join via webcast on Burcon's website under 'Presentations' or dial in using 1-800-717-1738 (North America) or 1-646-307-1865 (International) with Conference ID: 37581.

What is Burcon's (BRCNF) strategy for bringing their protein portfolio to market?

Burcon plans to bring their entire protein portfolio to market with full operational control, following the facility acquisition by their alliance partner Re ProMan

How can investors submit questions for Burcon's (BRCNF) February 2025 presentation?

Investors can submit questions in advance by emailing plam@burcon.ca, and there will also be a live Q&A session following the presentation.